RALEIGH, N.C.--(BUSINESS WIRE)--NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Chief Executive Officer Pierre Legault and President and Chief Scientific Officer J. Wesley Fox will present a corporate overview of the Company and meet with investors at the Cowen and Company 35th Annual Health Care Conference in Boston.
Help employers find you! Check out all the jobs and post your resume.
